Role of insulin‐like growth factor‐I in the treatment of painful small fiber predominant neuropathy

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of the peripheral nervous system

• Publication date

  2004-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1085-9489.2004.09311.xPMID 15363067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical localization of insulin-like growth factor I in the adult rat

  2004cited by this paper
• Autonomic impairment in painful neuropathy

  2001cited by this paper
• The pharmacological basis of contemporary pain management.

  2000cited by this paper
• Neurotrophins and other growth factors in the regenerative milieu of proximal nerve stump tips

  2000cited by this paper
• Neurotrophic Factors in Peripheral Neuropathies: Therapeutic Implications

  1999cited by this paper
• IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment.

  1999cited by this paper
• A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group.

  1998cited by this paper
• A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis

  1998cited by this paper
• Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal.

  1998cited by this paper
• Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group.

  1997cited by this paper
• Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice.

  1997cited by this paper
• Neurotrophic factors in the treatment of neurotoxicity: an overview.

  1996cited by this paper
• A standard test of heat-pain responses using CASE IV.

  1996influential reference
• Insulin‐like growth factors protect against diabetic neuropathy: Effects on sensory nerve regeneration in rats

  1995cited by this paper
• The importance of placebo effects in pain treatment and research.

  1994cited by this paper
• Role of insulin-like growth factors in peripheral nerve regeneration.

  1994cited by this paper
• IGF‐I Stimulates Chick Sympathetic Neuron Proliferation In Vitro and In Vivo

  1993cited by this paper
• Insulin‐like Growth Factor Binding Proteins in Nervous‐Tissue‐Derived Cells

  1993cited by this paper
• Cool, warm, and heat‐pain detection thresholds

  1993influential reference
• The Use of Insulin‐like Growth Factor I in the Prevention of Vincristine Neuropathy in Mice

  1993influential reference
• The Potential of Insulin‐like Growth Factor‐I as a Therapeutic for the Treatment of Neuromuscular Disorders

  1993cited by this paper
• Insulin-like growth factor II increases the rate of sciatic nerve regeneration in rats.

  1993cited by this paper
• 14 - Neurobiology of Insulin and Insulin-Like Growth Factors

  1993cited by this paper
• The Rochester Diabetic Neuropathy Study

  1991cited by this paper
• Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve.

  1989influential reference
• Insulin-like growth factor (IGF-1) as a stimulator of regeneration in the freeze-injured rat sciatic nerve.

  1989influential reference
• Relationship of insulin-like growth factor II gene expression in muscle to synaptogenesis.

  1989cited by this paper
• Pain in peripheral neuropathy related to rate and kind of fiber degeneration

  1976cited by this paper
• The reliability of a linear analogue for evaluating pain

  1976cited by this paper

• Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management

  2023cites this paper
• Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis

  2021cites this paper
• A Systematic Review of Pharmacologic and Rehabilitative Treatment of Small Fiber Neuropathies

  2020cites this paper
• A Systematic Review of the Diagnostic Methods of Small Fiber Neuropathies in Rehabilitation

  2020influential citation
• Drug therapy for chronic idiopathic axonal polyneuropathy.

  2017cites this paper
• NEUROPATHIC PAIN SECTION Original Research Article Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis

  2016cites this paper
• Drug therapy of neuropathic pain: current developments and future perspectives.

  2013cites this paper
• Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis.

  2012cites this paper
• Insulin-like growth factors in the peripheral nervous system.

  2012cites this paper
• Chemotherapie-induzierte Polyneuropathie (CIPN): Ein progredientes Problem im onkologischen Alltag

  2010cites this paper
• Insulin-like growth factors in the peripheral nervous system.

  2008cites this paper
• Minireview: Insulin-Like Growth Factors in the Peripheral Nervous System

  2008influential citation
• Chapter 27 Quantitative sensory testing.

  2006cites this paper
• Neurotrophins and Peripheral Neuropathies

  2006cites this paper
• The role of growth factors in the prevention and treatment of chemotherapy-induced peripheral neurotoxicity.

  2006cites this paper
• Influence of aging on thermal and vibratory thresholds of quantitative sensory testing

  2005cites this paper
• A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy.

  2004cites this paper
• Drug therapy for chronic idiopathic axonal polyneuropathy.

  2004cites this paper